PROTEINS ASSOCIATED WITH CELL GROWTH, DIFFERENTIATION, AND DEATH

PROTEINS ASSOCIATED WITH CELL GROWTH, DIFFERENTIATION, AND DEATH

Various embodiments of the invention provide human proteins associated with cell growth, differentiation, and death (CGDD) and polynucleotides which identify and encode CGDD. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KHARE, REENA, BULLOCH, SEAN, A, MARQUIS, JOSEPH, P, TRAN, UYEN, K, RAMKUMAR, JAYALAXMI, CHANG, HSIN-RU, ELLIOTT, VICKI, S, SWARNAKAR, ANITA, BECHA, SHANYA, D, RICHARDSON, THOMAS, W, EMERLING, BROOKE, M, LEE, SOO YEUN, TANG, Y. , TOM, BAUGHN, MARIAH, R, GRIFFIN, JENNIFER, A, KABLE, AMY, E, YUE, HENRY, KAREHT, STEPHANIE, K, CHAWLA, NARINDER, K
Format: Patent
Sprache:eng ; fre
Schlagworte:
CHEMISTRY
DERIVATIVES THEREOF
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SUGARS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Various embodiments of the invention provide human proteins associated with cell growth, differentiation, and death (CGDD) and polynucleotides which identify and encode CGDD. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of CGDD. Différents modes de réalisation de cette invention concernent des protéines humaines associées à la croissance, la différentiation et la mort cellulaires (CGDD), ainsi que des polynucléotides qui identifient et codent pour CGDD. Des modes de réalisation de cette invention concernent également des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. D'autres modes de réalisation de cette invention concernent des procédés permettant de diagnostiquer, traiter ou prévenir des troubles associés à l'expression aberrante de CGDD.